Quick Answer
ANGIODYNAMICS INC reported Total Revenue of $292.50 million for fiscal year 2025.
ANGIODYNAMICS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $292.50M -3.8% |
$303.91M -10.3% |
$338.75M +7.1% |
$316.22M +8.7% |
$291.01M +10.2% |
$264.16M -2.4% |
| Revenue (ASC 606) | $292.50M -3.8% |
$303.91M -10.3% |
$338.75M +7.1% |
$316.22M +8.7% |
$291.01M +10.2% |
$264.16M |
| Net Income | -$33.99M +81.6% |
-$184.35M -251.5% |
-$52.44M -97.5% |
-$26.55M +15.9% |
-$31.55M +81.1% |
-$166.79M -371.9% |
| Diluted EPS | -$0.83 +81.9% |
-$4.59 -245.1% |
-$1.33 -95.6% |
-$0.68 +17.1% |
-$0.82 +81.3% |
-$4.39 -367.7% |
| Total Assets | $280.14M -11.8% |
$317.67M -40.4% |
$532.64M -3.6% |
$552.75M -1.5% |
$561.44M -5.5% |
$594.21M -29.0% |
| Cash and Equivalents | $55.89M -26.5% |
$76.06M +70.5% |
$44.62M +54.8% |
$28.82M -40.1% |
$48.16M -11.5% |
$54.44M -76.1% |
| Long-Term Debt | — | $0.00 -100.0% |
$49.82M +99.3% |
$25.00M | — | — |
| Stockholders Equity | $182.97M -11.0% |
$205.59M -45.7% |
$378.30M -10.9% |
$424.49M -3.4% |
$439.46M -3.4% |
$454.87M -26.0% |
| R&D Expense | $26.22M -16.8% |
$31.51M +5.5% |
$29.88M -2.8% |
$30.74M -15.5% |
$36.39M +22.6% |
$29.68M +5.0% |
| Operating Income | -$39.95M +79.2% |
-$192.44M -276.0% |
-$51.18M -79.8% |
-$28.47M +19.3% |
-$35.28M +78.9% |
-$167.10M -1678.4% |
| Gross Profit | $157.71M +1.9% |
$154.70M -11.2% |
$174.25M +5.1% |
$165.73M +5.7% |
$156.79M +4.3% |
$150.27M -3.7% |
| Shares Outstanding | 40.99M +1.4% |
40.43M +2.1% |
39.61M +1.1% |
39.17M +1.6% |
38.55M +1.2% |
38.08M +1.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | November 30, 2025 | $79.43M | +9.0% | +4.9% |
| Revenue (ASC 606) | November 30, 2025 | $79.43M | +9.0% | +4.9% |
| Net Income | November 30, 2025 | -$6.35M | +40.9% | +41.8% |
| Diluted EPS | November 30, 2025 | -$0.15 | +42.3% | +42.3% |
| Total Assets | November 30, 2025 | $269.68M | -7.5% | +1.5% |
| Cash and Equivalents | November 30, 2025 | $41.64M | -23.0% | +7.4% |
| Long-Term Debt | August 31, 2013 | $129.38M | — | -4.2% |
| Stockholders Equity | November 30, 2025 | $176.33M | -5.6% | -1.4% |
| R&D Expense | November 30, 2025 | $7.77M | +20.7% | +21.1% |
| Operating Income | November 30, 2025 | -$6.12M | +44.8% | +42.5% |
| Gross Profit | November 30, 2025 | $44.78M | +12.2% | +7.0% |
| Shares Outstanding | November 30, 2025 | 41.57M | +1.8% | +0.3% |
- ANGIODYNAMICS INC reported Total Revenue of $292.50 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -3.8% in Total Revenue compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Revenue (ASC 606) of $292.50 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -3.8% in Revenue (ASC 606) compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Net Income of -$33.99 million for fiscal year 2025.
- ANGIODYNAMICS INC showed an increase of +81.6% in Net Income compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Diluted EPS of $0.83 per share (loss) for fiscal year 2025.
- ANGIODYNAMICS INC showed an increase of +81.9% in Diluted EPS compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Total Assets of $280.14 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -11.8% in Total Assets compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Cash and Equivalents of $55.89 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -26.5% in Cash and Equivalents compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Long-Term Debt of $0.00 for fiscal year 2024.
- ANGIODYNAMICS INC showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Stockholders Equity of $182.97 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -11.0% in Stockholders Equity compared to the prior fiscal year.
- ANGIODYNAMICS INC reported R&D Expense of $26.22 million for fiscal year 2025.
- ANGIODYNAMICS INC showed a decrease of -16.8% in R&D Expense compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Operating Income of -$39.95 million for fiscal year 2025.
- ANGIODYNAMICS INC showed an increase of +79.2% in Operating Income compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Gross Profit of $157.71 million for fiscal year 2025.
- ANGIODYNAMICS INC showed an increase of +1.9% in Gross Profit compared to the prior fiscal year.
- ANGIODYNAMICS INC reported Shares Outstanding of 40.99 million shares for fiscal year 2025.
- ANGIODYNAMICS INC showed an increase of +1.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: